Eastman 3rd Quarter 2026 Sales and Earnings Results Conference Call - EASTMAN CHEMICAL CO

Explicit Guidance:

• Revenue: Projected to reach up to $100 million from the Circular (chemical recycling) business in 2027; 2026 guidance implies a "minimum" of $100 million for the full year, with early 2027 expectations potentially higher. Advanced Materials (AM) and Acetate & Fibers (AF) segments expect volume growth in 2027 relative to 2026.
• Volume/Mix: Full-year 2026 AM volume mix growth expected at 3%; Q4 2026 requires high-single-digit volume growth to achieve this. 2027 volume growth expected in AM, AF, and Fibers.
• Operating Cash Flow: Full-year 2026 operating cash flow guidance lowered to ~$850 million (from $900 million) due to working capital build-up; 2027 outlook anticipates "significant cash flow above the $850 million" if conditions normalize and working capital releases (estimated $560 million working capital build to release in Q4 2026).
• Capital Expenditures (CapEx): 2026 CapEx expected at $400 million; 2027 baseline CapEx expected around $500 million. DOE grant covering 30–50% of capital costs for the Kingsport expansion (including first plant debottlenecking and second plant) will keep the incremental investment "within planned capex for 2027."
• EBITDA/Financials: 2027 EBITDA expected to remain stable relative to 2026 despite projected mid-single-digit price degradation in the Acetate (TOE) sector, driven by volume improvements and asset utilization tailwinds. Circular segment 2026 earnings estimated at ~$20 million on $100 million revenue.
• Pricing/Cost: Anticipated mid-single-digit price declines in Acetate (TOE) for 2027. 2027 earnings expected to be "moderately below" 2026 levels in Chemical Intermediates (CI) due to current Q4 headwinds, but not significantly impacted by CI given specialty growth.

Business-Segment Outlook:

• Circular Economy: Revenue expected to grow to ~$100 million in 2026, with momentum continuing into 2027. The converted R-PET line is now available for full-year 2027 production, supporting growth with major brands (e.g., Pepsi). Methanolysis plant second unit expected to launch mid-2028 with lower capex than Longview due to reused infrastructure and learnings.
• Advanced Materials (AM): Expected to deliver mid-single-digit volume growth in a challenged market; Q4 2026 projected to outperform Q3 due to "ReNew" volume momentum and inventory rebuilding. Performance film market in China remains challenged (down ~20%) but stabilized; North America holding steady.
• Acetate & Fibers: Expect volume improvement in 2027 due to destocking by independents and multinationals ending. Market share regained by Eastman in 2026 due to disciplined pricing and low cost position. 2027 pricing expected to decline mid-single digits, but earnings stability targeted via volume and utilization gains.
• Chemical Intermediates (CI): Q4 2026 pressured by narrow propane-propylene spreads; 2027 outlook sees spreads returning to 10-year averages (~27–28 cents), potentially adding $30–40 million in earnings relative to Q4 2026 if the arbitrage closes.
• Operations: Triton line and polymer conversion delays (approx. 1 month each) were Q3 2026 specific; lines running well in Q4 with no carryover impact. Planned turnarounds pushed from Q3 to Q4 2026, creating temporary working capital pressure.

Market and Competitive Outlook:

• Demand Trends: Discretionary markets (Auto, Building Construction, Consumer Durables) remain challenged by stagflation, interest rates, and housing weakness (US/EU down ~20%). 2026 auto sales expected down 3–4%; consumer durables growth constrained but resilient due to employed consumers.
• Competitive Landscape: No material capacity expansions expected from Japanese competitors in interlayer markets due to weak demand. Eastman expects to regain market share lost in 2024–2025 in Acetate. Industry consolidation (Genos/Sirdia) viewed as a potential stabilizing force due to high-cost assets and focus on cost synergies rather than capacity expansion.
• Pricing & Spreads: Q4 2026 propane-propylene spread historically narrow (14 cents vs. 27-cent average); expected to close quickly as Asian imports (China) constrain US supply and European crackers shut down.
• Supply Chain: US manufacturing job creation and supply chain security (re-industrialization) are key drivers for the DOE-backed project.

Macro / Industry Outlook:

• Geopolitics: Iran conflict driving sustained high raw material costs (PX, oil) and volatility through Q4 2026. Resolution of the conflict viewed as a potential upside stimulus for consumer behavior in 2027.
• Economy: Persistent stagflation since 2022 with no significant recovery; consumer behavior characterized by caution rather than job losses. Market stabilization depends on conflict resolution and economic clarity.
• Commodities: Oil prices and PX levels expected to remain elevated; 2027 outlook assumes normalization of raw material costs and spreads returning to historical averages.
• Tariffs/Trade: Mention of "Trade War" impact in 2025 hampering recovery; current outlook assumes stability if conflicts resolve.

Strategic Initiatives:

• DOE Grant Reinstatement: Grant covers 30–50% of capital costs for Kingsport expansion (debottlenecking first plant, feed processing, polymer/infrastructure, and second plant). Scope includes up to 50% of Capex for the first plant's capacity increase and the second plant.
• M&A/Asset Acquisition: Plan to acquire low-cost, underutilized American recycling assets and shuttered polymer lines/infrastructure to support the second methanolysis plant, minimizing new build capital.
• Metathesis Project (E2P): Repurposing an existing cracker to produce propylene. Capacity doubled from original plan. Expected to be online mid-2028. Earnings benefit estimated at $100 million annually (range $75–125 million), with payback of 1–2 years.
• Capacity Additions: Conversion of Triton line and polymer line to PTT capacity now complete. Second methanolysis plant expected to utilize existing infrastructure to reduce Capex.
• Product Launches: "ReNew" program driving volume growth in Advanced Materials; potential announcements on new customer commitments for R-PET packaging in Q1 2027.

Risks and Headwinds to Outlook:

• Geopolitical Escalation: Potential re-escalation of the Iran war could prolong high raw material costs and volatility, impacting Q4 2026 and 2027 earnings.
• Market Demand: Continued weakness in China (down ~20%), US/EU housing, and auto sales; potential consumer destocking if economic uncertainty persists.
• Working Capital: Q3/Q4 2026 working capital built up (~$560 million) due to raw material inflation and security stockpiling; release dependent on Q4 turnover and 2027 demand normalization.
• Operational Execution: Startup delays on new lines (e.g., bad pumps) pose execution risks, though current impact is contained to Q3 2026.
• Pricing Pressure: Mid-single-digit price declines expected in Acetate (TOE) in 2027 due to contract expirations and market adjustments.
• Arbitrage Closure Timing: Propane-propylene arbitrage may not close instantly due to shipping constraints linked to the Iran conflict, potentially delaying margin recovery.

Management Tone on the Future:

• Confidence Level: Cautiously optimistic. Management expresses strong confidence in the ability to maintain revenue growth and earnings stability in 2027 despite macro headwinds.
• Hedges: Frequent qualifiers regarding the need to await economic clarity in January 2027 before providing detailed 2027 guidance. Conservative stance on 2027 Circular revenue ("minimum $100 million").
• Changes vs. Prior: Downgraded 2026 cash flow guidance ($900M to $850M) due to inflation and working capital; upgraded confidence in 2027 cash flow tailwinds once working capital releases.
• Strategic Shift: Strong emphasis on capital discipline, utilizing existing assets to lower Capex, and leveraging the DOE grant to enhance competitiveness and reduce long-term capital intensity.

Miscellaneous:

• Working Capital Dynamics: Inventory days reduced from 115 (year-end 2025) to 105 (end of Q3 2026). Focus on reducing inventory in Advanced Materials and Fibers through volume growth in 2027.
• Cost Structure: 2026 price-cost headwinds totaling ~$30 million (half in Q4); 2027 outlook assumes price recovery and tailwinds if oil prices return to $80s/barrel.
• Project Economics: Metathesis project described as "phenomenally great" with high capital efficiency; expected to reduce earnings volatility by minimizing bulk ethylene sales exposure.